Abstract
Risk assessment is a critical process that involves identifying, analyzing, and evaluating potential hazards and risks associated with the drug substance or product throughout the product development and manufacturing process. Quality by design (QbD) principles and quality risk management (QRM) are encouraged by the US FDA for consistent adherence to predefined quality attributes and specifications. QRM should be applied during various stages of product development to identify and mitigate potential risks, using technical risk assessment methodology to facilitate science-based decision-making in a systematic, objective, and efficient manner. Semi-quantitative risk assessment (SQRA) can help speed decision-making in fast-paced industrial environments by prioritizing projected product risks that may impact end users. In pharmaceutical manufacturing, it is often challenging to identify and define failures, making product and process risk more relevant and practical to assess. The use of software with an audit trail can efficiently update a risk assessment platform for a specific quality attribute, reducing the need for additional time for rework or repeat risk assessments for complex multiunit operations. Modern quality systems and risk assessment tools that utilize product and process knowledge can simplify regulatory approval requirements for post-approval changes to facilities, equipment, and processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
PDA (2012) TR 54 implementation of quality risk management for pharmaceutical and biotechnology manufacturing operations. Parenteral Drug Association
Pazhayattil AB, Sayeed-Desta N, Chen S, Ingram M (2020) A Semiquantitative risk assessment methodology fit for biopharmaceutical life cycle stages. PDA J Pharm Sci Technol 74(4):423–434
Strong JC, McDermott TS, Oliver Heinzerling H, Claycamp G (2017) The risk of trusting risk priority numbers. AAPS Newsl 20:14–18
Murray KS, Reich S (2011) Quality Risk Management (QRM) tool selection: getting to right first time. Pharmaceutical Engineering
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pazhayattil, A.B., Sharma, S., Philip, J.P., Gischewski-Silva, M., Ingram, M. (2023). Quality Risk Management (QRM). In: Technology Transfer. AAPS Introductions in the Pharmaceutical Sciences, vol 10. Springer, Cham. https://doi.org/10.1007/978-3-031-32192-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-32192-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32191-7
Online ISBN: 978-3-031-32192-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)